… patients with COPD. This article is based on a review of the literature (PubMed: COPD AND
inhaled corticosteroids… evidence for the efficacy and safety of ICS use in patients with COPD. …

… -benefit ratio of inhaled corticosteroid treatment for COPD by … of inhaled corticosteroid treatment
in patients with COPD with … risk-benefit ratio of inhaled corticosteroid treatment for COPD. …

… of inhaled corticosteroids (ICS) in combination with bronchodilators in patients with COPD …
exacerbations and to improve the lung function and patients’ quality of life. However, their use …

… with stable chronic obstructive pulmonary disease (COPD) … inhaled corticosteroids are of
functional benefit in patients who did not show improvement with a trial of oral corticosteroids. …

… in tackling COPD. However, far greater amounts of money are spent on drug therapy for COPD
… supporting treatment with inhaled corticosteroids (ICS) in COPD, including treatment with …

… patients with COPD, we propose that: 1) ICS should not be used as a single, stand-alone
therapy in COPD; 2) patients … 3) the risk of pneumonia in COPD patients using ICS is higher in …

… the biological response to inhaled steroids in these COPD patients. COPD usually is
characterized … In this scenario, it is conceivable that if steroids work in patients with COPD, their …

… power to assess the effect of inhaled corticosteroids on all-cause … inhaled corticosteroids
affect all-cause and cause-specific mortality in COPD, we pooled retrospective individual patient …

… patients with a rapidly progressive form of COPD, we hypothesize that treatment with inhaled
corticosteroids … of early morbidity and mortality in patients with a low lung function level and …

… with COPD. Elevated levels of systemic and pulmonary inflammation in patients with stable
COPD have led to the development of inhaled corticosteroid (ICS) therapies for such patients…